Nuo Therapeutics, Inc. (AURX) stock
AURXOTCSurgical & Medical Instruments & ApparatusFiscal year ends December 31
$1.26−0.04 (-3.08%)
Close on Oct 19, 2026Market cap $60.99MP/E –Yield –
Nuo Therapeutics operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Nuo Therapeutics's operating cash flow for the twelve months ending Jun 30, 2026 was -$2.15M. For fiscal 2025 it was -$864.97K. The highest annual figure on record is -$53.82K in fiscal 2020.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$864.97K | – |
| FY2024 | Dec 31, 2024 | -$2.23M | – |
| FY2023 | Dec 31, 2023 | -$3.17M | – |
| FY2022 | Dec 31, 2022 | -$3.71M | – |
| FY2021 | Dec 31, 2021 | -$119.96K | – |
| FY2020 | Dec 31, 2020 | -$53.82K | – |
| FY2019 | Dec 31, 2019 | -$921.67K | – |
| FY2018 | Dec 31, 2018 | -$874.39K | – |
| FY2017 | Dec 31, 2017 | -$4.90M | – |
| FY2015 | Dec 31, 2015 | -$14.39M | – |
| FY2014 | Dec 31, 2014 | -$17.42M | – |
| FY2013 | Dec 31, 2013 | -$11.40M | – |
| FY2012 | Dec 31, 2012 | -$11.39M | – |
| FY2011 | Dec 31, 2011 | -$4.24M | – |
| FY2010 | Dec 31, 2010 | -$3.54M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$236.48K | -190.1% |
| Q1 FY2026 | Mar 31, 2026 | -$784.27K | -43073.8% |
| Q4 FY2025 | Dec 31, 2025 | -$422.65K | – |
| Q3 FY2025 | Sep 30, 2025 | -$706.52K | – |
| Q2 FY2025 | Jun 30, 2025 | $262.37K | – |
| Q1 FY2025 | Mar 31, 2025 | $1.83K | – |
| Q4 FY2024 | Dec 31, 2024 | -$490.54K | – |
| Q3 FY2024 | Sep 30, 2024 | -$487.47K | – |
| Q2 FY2024 | Jun 30, 2024 | -$691.17K | – |
| Q1 FY2024 | Mar 31, 2024 | -$562.45K | – |
| Q4 FY2023 | Dec 31, 2023 | -$671.41K | – |
| Q3 FY2023 | Sep 30, 2023 | -$794.88K | – |
| Q2 FY2023 | Jun 30, 2023 | -$905.89K | – |
| Q1 FY2023 | Mar 31, 2023 | -$795.60K | – |
| Q4 FY2022 | Dec 31, 2022 | -$821.69K | – |
| Q3 FY2022 | Sep 30, 2022 | -$1.01M | – |
| Q2 FY2022 | Jun 30, 2022 | -$1.14M | – |
| Q1 FY2022 | Mar 31, 2022 | -$737.33K | – |
| Q4 FY2021 | Dec 31, 2021 | -$106.95K | – |
| Q3 FY2021 | Sep 30, 2021 | -$3.16K | – |
| Q2 FY2021 | Jun 30, 2021 | -$5.68K | – |
| Q1 FY2021 | Mar 31, 2021 | -$4.17K | – |
| Q4 FY2020 | Dec 31, 2020 | -$33.57K | – |
| Q3 FY2020 | Sep 30, 2020 | -$13 | -100.2% |
| Q2 FY2020 | Jun 30, 2020 | -$11.20K | – |
| Q1 FY2020 | Mar 31, 2020 | -$9.04K | – |
| Q4 FY2019 | Dec 31, 2019 | -$302.08K | -178.1% |
| Q3 FY2019 | Sep 30, 2019 | $8.29K | – |
| Q2 FY2019 | Jun 30, 2019 | -$176.28K | – |
| Q1 FY2019 | Mar 31, 2019 | -$451.61K | – |
| Q4 FY2018 | Dec 31, 2018 | $386.76K | – |
| Q3 FY2018 | Sep 30, 2018 | -$438.92K | – |
| Q2 FY2018 | Jun 30, 2018 | -$275.65K | – |
| Q1 FY2018 | Mar 31, 2018 | -$546.58K | – |
| Q4 FY2017 | Dec 31, 2017 | -$1.20M | – |
| Q3 FY2017 | Sep 30, 2017 | -$1.41M | – |
| Q2 FY2017 | Jun 30, 2017 | -$1.01M | – |
| Q1 FY2017 | Mar 31, 2017 | -$1.28M | – |
See a number that looks wrong?